Establishment Labs Holdings Inc (ESTA) Stock Price, Quote & News

Company Profile

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment...

Industry: Medical Devices

Sector: Healthcare

Phone: 800 924 5072

Website: www.establishmentlabs.com

Address:

11401 century oaks terrace, suite 400, Austin, United States

gabrielillo Jun. 25 at 1:13 PM

$ESTA

0 · Reply

Lambster2 Jun. 25 at 12:08 PM

$ESTA Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index https://establishmentlabs2023cr.q4web.com/press-releases/press-releases-details/2026/Establishment-Labs-Added-to-Membership-of-U-S--Small-Cap-Russell-2000-Index/default.aspx

0 · Reply

StardustTrader Jun. 24 at 6:20 PM

$ESTA setting up a sell the news event. Keep powder dry for the pullback. Consider even taking some gains at these levels. Overall

1 · Reply

TriGuy8542 Jun. 24 at 3:48 PM

$ESTA bought a smidge more. This company is delivering on growth and research in a consistent manner and should be rewarded long term. Looking for either an acquisition over the next 18 months or the company to continue to go it alone and transform plastic surgery. Profitbility would easily be achieved after an acquisition. Each day this doesn’t happen makes Me want the company to continue to forge forward on its own. Easily worth $20B if they continue forward.

0 · Reply

Nick_Drendel Jun. 24 at 12:00 AM

$ESTA Looksmaxxing stock looking good.

0 · Reply

TriGuy8542 Jun. 22 at 3:53 PM

$OUST $ESTA thank you both for today. Strength is shown in times of weakness

0 · Reply

Bio_Pharm Jun. 19 at 1:30 AM

$ESTA What do you think the future target is for end of this year? How high you think this stock can go.

2 · Reply

TriGuy8542 Jun. 18 at 2:42 PM

$ESTA added this morning. Small DCA adds

0 · Reply

Lambster2 Jun. 18 at 11:40 AM

$ESTA Establishment Labs (NASDAQ: ESTA) Buy (1) ESG Score: 48/100 Price Target: $100.00 (Prior $95.00) Plastic Surgeon KOL Roundtable Download - Part 2 THE TD COWEN INSIGHT Our bull thesis is that ESTA is not merely taking share; it is redefining the standard of care in augmentation around a branded, minimally invasive, premium patient experience enabled by revolutionary implant technology. We believe Motiva/Ergonomix implants combined with the Preservé and Mia MIS techniques have the potential to capture a majority share position and expand the breast implant TAM.

1 · Reply

Lambster2 Jun. 18 at 11:39 AM

$ESTA Establishment Labs (NASDAQ: ESTA) Buy (1) ESG Score: 48/100 Price Target: $100.00 (Prior $95.00) Best Smidcap Ideas: ESTA-blishing a New Standard in Breast Augmentation THE TD COWEN INSIGHT We are elevating ESTA to our top Smidcap pick driven by the company's unique position as the only innovator in an otherwise commoditized market. Surgeon demand for the company's disruptive MIS procedural approaches and differentiated implant technologies alongside strong management execution underpin our confidence in the continuation of the beat-and-raise story. We raise our PT to $100.

0 · Reply

Establishment Labs added to membership of U.S. small-cap Russell 2000 Index

May 22, 2026, 1:00 PM EDT - 4 weeks ago

Establishment Labs Holdings Transcript: AGM 2026

May 18, 2026, 8:00 AM EDT - 5 weeks ago

Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer

2026-05-07T13:25:05.000Z - 7 weeks ago

Establishment Labs price target raised to $90 from $88 at BTIG

2026-05-07T02:08:06.000Z - 7 weeks ago

Establishment Labs price target raised to $76 from $65 at Citi

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Establishment Labs Holdings Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Establishment Labs Holdings Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Establishment Labs Holdings Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

Establishment Labs Reports First Quarter 2026 Financial Results

May 4, 2026, 11:16 AM EDT - 7 weeks ago

Weight-loss revolution sparks new appetite for aesthetics firms

APYX EOLS INMD

2026-04-30T14:44:49.000Z - 7 weeks ago

Establishment Labs refinances credit facility

Apr 30, 2026, 8:53 AM EDT - 2 months ago

Establishment Labs® Refinances Credit Facility

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Establishment Labs Holdings Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6

Apr 10, 2026, 8:00 AM EDT - 2 months ago

Establishment Labs Holdings Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 2 months ago

Establishment Labs Holdings Proxy statement: Proxy filing

2026-04-07T12:14:07.000Z - 2 months ago

Establishment Labs surpasses more than 5M Motiva devices in market

Apr 7, 2026, 8:00 AM EDT - 2 months ago

Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market

2026-04-07T11:02:33.000Z - 2 months ago

Establishment Labs price target lowered to $65 from $74 at Citi

2026-03-24T18:06:49.000Z - 3 months ago

Establishment Labs selloff ‘unwarranted and overdone,’ says Mizuho

2026-03-11T09:26:44.000Z - 3 months ago

Establishment Labs price target lowered to $74 from $81 at Citi

Mar 2, 2026, 9:10 AM EST - 4 months ago

Establishment Labs Holdings Transcript: TD Cowen 46th Annual Health Care Conference

2026-02-26T14:12:41.000Z - 4 months ago

Establishment Labs price target raised to $90 from $85 at Canaccord

2026-02-25T13:23:45.000Z - 4 months ago

Establishment Labs price target raised to $90 from $85 at Stephens

2026-02-25T13:14:33.000Z - 4 months ago

Establishment Labs price target raised to $90 from $85 at Stephens

2026-02-25T12:48:19.000Z - 4 months ago

Establishment Labs price target raised to $95 from $88 at TD Cowen

2026-02-25T12:32:49.000Z - 4 months ago

Establishment Labs price target raised to $100 from $90 at Mizuho

Feb 24, 2026, 8:30 AM EST - 4 months ago

Establishment Labs Holdings Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:30 AM EST - 4 months ago

Establishment Labs Holdings Annual report: Q4 2025

Feb 24, 2026, 8:30 AM EST - 4 months ago

Establishment Labs Holdings Earnings release: Q4 2025

2026-02-24T13:11:25.000Z - 4 months ago

Establishment Labs CFO Raj Denhoy to switch roles, Cassandra Harris to succeed

GCO

Feb 24, 2026, 8:00 AM EST - 4 months ago

Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

Feb 24, 2026, 8:00 AM EST - 4 months ago

Establishment Labs Announces Leadership Transition to Support Next Phase of Growth

Feb 18, 2026, 8:00 AM EST - 4 months ago

Establishment Labs to Present at TD Cowen's 46th Annual Health Care Conference

Feb 10, 2026, 8:00 AM EST - 4 months ago

Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24

Jan 14, 2026, 12:45 PM EST - 5 months ago

Establishment Labs Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 12:45 PM EST - 5 months ago

Establishment Labs Holdings Slides: 44th Annual J.P. Morgan Healthcare Conference

2026-01-12T13:12:01.000Z - 5 months ago

Establishment Labs sees Q4 revenue $64M-$65M, consensus $63.76M

2026-01-12T13:11:28.000Z - 5 months ago

Establishment Labs sees FY25 revenue $210.5M-$211.5M, consensus $210.27M

Jan 12, 2026, 8:00 AM EST - 5 months ago

Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

2026-01-01T17:05:15.000Z - 6 months ago

Establishment Labs rises -0.1%

Dec 31, 2025, 8:00 AM EST - 6 months ago

Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference

Dec 29, 2025, 8:00 AM EST - 6 months ago

Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

Nov 19, 2025, 3:30 AM EST - 7 months ago

Establishment Labs Holdings Transcript: Jefferies London Healthcare Conference 2025

Nov 7, 2025, 8:00 AM EST - 8 months ago

Establishment Labs to Present at Jefferies London Healthcare Conference

Nov 5, 2025, 8:30 AM EST - 8 months ago

Establishment Labs Holdings Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Establishment Labs Holdings Quarterly report: Q3 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Establishment Labs Holdings Earnings release: Q3 2025

Nov 5, 2025, 8:00 AM EST - 8 months ago

Establishment Labs Reports Third Quarter 2025 Financial Results

Oct 22, 2025, 8:00 AM EDT - 8 months ago

Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5

gabrielillo Jun. 25 at 1:13 PM

$ESTA

0 · Reply

Lambster2 Jun. 25 at 12:08 PM

0 · Reply

StardustTrader Jun. 24 at 6:20 PM

$ESTA setting up a sell the news event. Keep powder dry for the pullback. Consider even taking some gains at these levels. Overall

1 · Reply

TriGuy8542 Jun. 24 at 3:48 PM

0 · Reply

Nick_Drendel Jun. 24 at 12:00 AM

$ESTA Looksmaxxing stock looking good.

0 · Reply

TriGuy8542 Jun. 22 at 3:53 PM

$OUST $ESTA thank you both for today. Strength is shown in times of weakness

0 · Reply

Bio_Pharm Jun. 19 at 1:30 AM

$ESTA What do you think the future target is for end of this year? How high you think this stock can go.

2 · Reply

TriGuy8542 Jun. 18 at 2:42 PM

$ESTA added this morning. Small DCA adds

0 · Reply

Lambster2 Jun. 18 at 11:40 AM

1 · Reply

Lambster2 Jun. 18 at 11:39 AM

0 · Reply

TriGuy8542 Jun. 17 at 7:05 PM

$ESTA great relative strength, added

0 · Reply

TriGuy8542 Jun. 15 at 5:54 PM

$ESTA order filled, thanks

0 · Reply

eeeeeeeeeeee Jun. 12 at 3:20 PM

$ESTA Partial +42%

0 · Reply

Lambster2 Jun. 12 at 11:30 AM

$ESTA Establishment Labs (NASDAQ: ESTA) Buy (1) ESG Score: 48/100 Price Target: $95.00 Plastic Surgeon KOL Roundtable Download - Part 1 THE TD COWEN INSIGHT Our KOL roundtable with 4 high-volume plastic surgeons reinforced our conviction that ESTA is evolving from an implant share-gainer into a category creator. Surgeons reported near-exclusive Motiva utilization, growing patient brand awareness, premium pricing power, and strong demand for Preservé, which seems to be expanding the breast augmentation market. Look for Part 2 next week. Reiterate Buy.

1 · Reply

Shlobby Jun. 12 at 3:18 AM

$ESTA run from 30 to 80 has similar setup to now. Long from early this week

0 · Reply

Lambster2 Jun. 11 at 5:45 PM

$ESTA Congrats to longs that held and believed. I think this could double in 3 years with a good chance of being bought out before then.

0 · Reply

TriGuy8542 Jun. 11 at 3:40 PM

$ESTA added

0 · Reply

YouOnlyLiveTwice Jun. 11 at 3:13 PM

$ESTA $90 next……

1 · Reply

StardustTrader Jun. 10 at 11:30 PM

$ESTA done told ya.

0 · Reply

SuperGreenToday Jun. 10 at 4:14 AM

$ESTA Share Price: $79.68 Contract Selected: Nov 20, 2026 $80 Calls Buy Zone: $9.86 – $12.18 Target Zone: $16.68 – $20.39 Potential Upside: 60% ROI Time to Expiration: 163 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Shlobby Jun. 9 at 7:07 PM

$ESTA looking great today took long around 77

0 · Reply

YouOnlyLiveTwice Jun. 9 at 6:05 PM

$ESTA Once we break $80 then $90 then it’s on to the next stratosphere

0 · Reply

Market Cap	2.53B
Revenue (ttm)	211.08M
Net Income (ttm)	-51.06M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-24.19%
Debt to Equity Ratio	16.82

Volume	789,100
Avg Vol	524,936
Day's Range	N/A - N/A
Shares Out	29.43M
Stochastic %K	79%
Beta	1.11
Analysts	Strong Sell
Price Target	$92.50